startup.bid
ZH
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

Olio Labs

Combination therapeutics for the world's toughest diseases

公司介绍

公司介绍(英文)

Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.

主题

所在地
远程
团队规模
5 名员工
YC 批次
Summer 2023
状态
运营中
阶段
早期阶段

同类创业公司与竞争对手

业务介绍:

Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its…

基本信息:

总部: 英国

融资:

€16M · Seed · 2026年10月

问答

Olio Labs 有多少名员工?

根据公司资料,共有 5 名员工。

Olio Labs 获得过融资吗?

我们的数据中没有 Olio Labs 的融资记录。

Olio Labs 有哪些同类公司和竞争对手?

同类创业公司:Numerion Labs、WhiteLab Genomics和Undecimal Bio。